Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine in Kolkata, India

Human Vaccines

Volumn 5, Issue 9, 2009, Pages 614-620

  Sur, Dipika ^a   Manna, Byomkesh ^a   Chakrabarty, Nandini ^a   Kaljee, Linda M ^b   Riel, Rosemary ^c   Pach, Alfred ^d   Kanungo, Suman ^a   Deen, Jacqueline ^d   Ochiai, R Leon ^d   Clemens, John ^d   Bhattacharya, S K ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d International Vaccine Institute   (South Korea)

Author keywords

India; Social behavioral research; Typhoid fever; Vaccine trial participation

Indexed keywords

HEPATITIS A VACCINE; TYPHOID VACCINE;

ACCESS TO INFORMATION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; EDUCATIONAL STATUS; FEMALE; HEALTH BEHAVIOR; HEALTH BELIEF; HEALTH CARE UTILIZATION; HUMAN; INDIA; MALE; MOSLEM; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REFUSAL TO PARTICIPATE; RESEARCH SUBJECT; SOCIAL BEHAVIOR; VACCINATION;

EID: 73649136786     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.9313     Document Type: Article

References (34)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bulletin of the World Health Organization 2004; 82:346-53.
2. Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, et al. Typhoid fever in children aged less than 5 years. Lancet 1999; 354:734-7.
3. Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing C, Bhattacharya SK, Agtini MD, et al. (in-press) A multi-center, population-based, prospective surveillance study of typhoid fever in 5 Asian countries: disease burden and implications for control.
4. Government of India. National Family Health Survey-NFHS 1998/1999. West Bengal, Preliminary Report. Economic Information Technology, Calcutta and International Institute for Population Sciences, Mumbai 1999.
5. Government of India. Multi-Year Strategic Plan for Immunization Strengthening. Department of Family Welfare, Ministry of Health and Family Welfare. Strategic Plan 2000.
6. Mandal S, Mandal MD, Pal NK. Antimicrobial Resistance Pattern of Salmonella typhi Isolates in Kolkata, India during 1991-2001: a Retrospective Study. Japan Journal of Infectious Disease 2002; 55:58-9.
7. Sur D, von Seidlein L, Manna B, Dutta S, Deb AK, Sarkar BL, et al. The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study. Tran R Soc Trop Med Hyg 2006; 100:725-33.
8. Paniker CK, Vimala KN. Transferable Chloramphenicol Resistance in Salmonella typhi. Nature 1972; 239:109-10.
9. Jesudasan MV, John TJ. Multiresistant Salmonella typhi in India. Lancet 1990; 336:252.
10. Saha MR, Dutta P, Palit A, Dutta D, Bhattacharya MK, Mitra U, et al. A note on Incidence of Typhoid Fever in Diverse Age Groups in Kolkata, India. Japan Journal of Infectious Disease 2000; 56:121-2.
11. Madhulika U, Harish BN, Parija SC. Current pattern in antimicrobial susceptibility of Salmonella typhi isolates in Ponbdicherry. Indian Journal of Medical Research 2004; 120:111-4.
12. Parry CM. The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Tran R Soc Trop Med Hyg 2004; 98:413-22.
13. Acosta CJ, Galindo CM, Deen JL, Ochiai RL, Lee HJ, von Seidlein V, et al. Vaccines against cholera, typhoid fever and shigellosis for developing countries. Expert Opin Biol Ther 2004; 4:1939-51.
14. Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. Immunogenicity, efficacy and serological correlative of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996; 14:435-8.
15. Hessel L, Debois H, Fletcher M, Dumas R. Experience with Salmonella typhi Vi capsular polysaccharide vaccine. European Journal of Clinical Microbiology and Infectious Diseases 1999; 18:609-20.
16. Nichter M. Vaccinations in the Third World: A consideration of community demand. In Nichter M, Nichter M, eds. Anthropology and International Health: South Asian Case Studies. Amsterdam: Gordon and Breach Publishers 2002; 329-66.
17. Streefland P, Chowdury AMR, Ramos-Jimenez P. Patterns of vaccination. Social Science and Medicine 1999; 49:1705-16.
18. WHO-UNAIDS Expert Group. Gender, Age and Ethnicity in HIV vaccine related trials. Report from a WHO-UNAIDS consultation, 26 to 28 August 2004, Lausanne Switzerland. AIDS 2005; 19:7-28.
19. Newman PA, Duan N, Kakinami L, Roberts K. What can HIV vaccine trials teach us about future HIV vaccine dissemination? Vaccine 2008; 26:2528-36.
20. Kaljee L, Pham V, Son ND, Hoa NT, Thiem VD, Canh G, et al. Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam. Tropical Medicine and International Health 2007; 12:25-36.
21. Kaljee LM, Pack R, Pach A, Nyamete A, Stanton B. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme. Journal of Health, Population and Nutrition 2004; 22:293-303.
22. Mays RM, Sturm LA, Zimet GD. Parental perspective on vaccinating children against sexually transmitted infections. Social Science and Medicine 2006; 58:1405-13.
23. Impicciatore P, Bosetti C, Schiavio S, Pandolfini C, Bonati M. Mothers as active partners in the prevention of childhood diseases: Maternal factors related to immunization status of preschool children in Italy. Preventive Medicine 2000; 31:49-55.
24. Sansom SL, Barker L, Corso PS, Brown C, Deuson R. Rotavirus vaccine and intus-susception: How much risk will parents in the United States accept to obtain vaccine benefits. American Journal of Epidemiology 2001; 154:1077-85.
25. Ramsey ME, Yarwood J, Lewis D, Campbell H, White JM. Parental confidence in measles, mumps and rubella vaccine: Evidence from vaccine coverage and attitudinal surveys. The British Journal of General Practice 2000; 52:912-6.
26. Chen X, Stanton B, Wang X, Nyamette A, Pach A, Kaljee L, et al. Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China. Vaccine 2006; 24:561-71.
27. Doran T, McCann R. Obstacles to influenza immunization in primary care. Journal of Public Health Medicine 2001; 23:329-34.
28. Chen X, Stanton B, Pach A, Nyamete A, Ochiai RL, Kaljee L. Adult perceived prevalence of enteric fever predicts laboratory-validated incidence of typhoid fever in children. Journal of Health, Population and Nutrition 2008; 25:469-78.
29. Feldman-Savelsberg P, Ndonko FT, Schmidt-Ehry B. Sterilizing vaccines or the politics of the womb: a retrospective study of a rumor in Cameroon. Medical Anthropology Quarterly 2000; 14:159-79.
30. Azzam H, Kaljee L. Vaccines and women: cultural and structural issues for acceptability. In Murty P, Lanford C, eds. Women's Global Health and Human Rights. New York: Jones and Bartlett 2009.
31. Clemens J, Brenner R, Rao M, Tafari N Lowe. Evaluating new vaccines for developing countries: Efficacy or effectiveness? Journal of the American Medical Association 1996; 275:390-7.
32. Clemens J, Jodar L. Translational research to assist policy decisions about introducing new vaccines in developing countries. Journal of Health, Population and Nutrition 2004; 22:223-31.
33. Lauria DT, Maskery B, Poulos C, Whittington D. An optimization model for reducing typhoid cases in developing countries without increasing public spending. Vaccine 2009; 27:1609-21.
34. Ochiai RL, Acosta CJ, Agtini M, Bhattacharya SK, Bhutta ZA, Canh G, et al. The use of typhoid vaccines in Asia: the DOMI experience. Clinical Infectious Diseases 2007; 45:34-8.